Overview

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

Status:
Unknown status

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

Study hypothesis is that the time from randomization to the increase of natriuresis (%), time to standardization of natriuresis daily profile, blood pressure profile and the percentage reduction of central hemodynamic parameters will be relatively changed over the study period by more than 15%.

Phase:

Phase 4

Details

Lead Sponsor:

Society of Specialists in Heart Failure

Treatments:

Torsemide